Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Clinical trial NCT04685616 · RECRUITING

Trial details

NCT number: NCT04685616
Sponsor: University College, London
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2022-04-14
Primary completion: 2030-09-01
Enrollment: 1042

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.